Efficacy and Safety of Tocilizumab in Adult's Still Disease
NCT01002781
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
10
Enrollment
OTHER_GOV
Sponsor class
Conditions
Adult's Still Disease
Interventions
DRUG:
Tocilizumab
Sponsor
Tel-Aviv Sourasky Medical Center
Collaborators
[object Object]
[object Object]
[object Object]